The emerging approach of this peptide represents a significant development in the management of type 2 diabetes. Distinct from existing medications, tirzepatide targets dual pathways – glucagon-like peptide-1 (GLP-1) https://tirzepatidepeptide358686.bloggadores.com/40773686/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment